Read our research strategy

Our research and innovation strategy builds on what’s already been achieved and sets out how we’ll continue to lead the global research effort to make tomorrow’s treatment a reality.

We’ve developed our priorities for the next five years with people affected by MND, health and social care professionals and our research partners, so we know we’re focusing on what really matters.

Read our full research strategy below.

This content is hosted by a third party

You must consent to targeting cookies set by the third party to view this content.

Manage cookie preferences

Download our full research strategy (PDF)

“This strategy is unapologetically ambitious as we seek to make further inroads into our understanding of MND, innovate in the development of new treatments and ensure more people have the opportunity to take part in clinical trials.”  
Mike Rogers, Director of Research and Innovation

This content is hosted by a third party

“This strategy is unapologetically ambitious as we seek to make further inroads into our understanding of MND, innovate in the development of new treatments and ensure more people have the opportunity to take part in clinical trials.”

Mike Rogers, Director of Research and Innovation

“This strategy is unapologetically ambitious as we seek to make further inroads into our understanding of MND, innovate in the development of new treatments and ensure more people have the opportunity to take part in clinical trials.”  